<DOC>
	<DOC>NCT02432599</DOC>
	<brief_summary>The rationale for the proposed pilot study is to investigate the ability of PET-CT with F18-choline to detect and locate the parathyroid adenoma in patients with primary hyperparathyroidism and negative or non-contributory MIBI (Tc-99m sestamibi) and cervical ultrasound, in order to avoid unnecessary bilateral cervical exploration.</brief_summary>
	<brief_title>Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas</brief_title>
	<detailed_description />
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Parathyroid Neoplasms</mesh_term>
	<mesh_term>Choline</mesh_term>
	<criteria>Patient aged 18 years or more; Patient with a primary hyperparathyroidism and witj a negative or noncontriburatory MIBI parathyroid scintigraphy and neck ultrasonography, for which surgical resection is planned; Confirmation of the diagnosis of primary hyperparathyroidism on laboratory tests Affiliate to a social security system; Patient written informed consent. Patient deprived of liberty, under guardianship; Any medical or psychological condition witch could compromise the capacity of the patient to participate in the study; Pregnant or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>F18-choline</keyword>
</DOC>